Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) was the recipient of unusually large options trading on Wednesday. Investors acquired 15,971 call options on the company. This represents an increase of approximately 169% compared to the average volume of 5,938 call options.
Insider Buying and Selling
In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. Company insiders own 0.62% of the company’s stock.
Hedge Funds Weigh In On Synopsys
A number of large investors have recently modified their holdings of SNPS. Alpine Bank Wealth Management lifted its holdings in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. lifted its stake in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys during the third quarter valued at about $27,000. SOA Wealth Advisors LLC. purchased a new stake in Synopsys during the third quarter valued at about $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys in the fourth quarter worth about $28,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Key Synopsys News
- Positive Sentiment: Q1 beat and big revenue upside — Synopsys reported non‑GAAP EPS $3.77 (above estimates) and revenue of $2.409B, up ~65% YoY, driven by Design Automation and the Ansys contribution; headline results support longer‑term AI chip‑design demand. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
- Positive Sentiment: Better FY26 EPS outlook — management set FY26 non‑GAAP EPS guidance ~14.38–14.46, well above consensus, suggesting management sees stronger full‑year earnings even if near‑term revenue cadence is choppy. Synopsys’ FY26 guidance likely conservative as analysts reiterate strong ratings
- Positive Sentiment: $2.0B buyback — the board authorized up to $2B of repurchases, a direct capital return that can support the stock and offset dilution from the Ansys deal. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
- Neutral Sentiment: Unusual options and whale activity — heavy call buying and large options volume were observed around the release, which can amplify intraday moves but may reflect short‑term, speculative positioning rather than conviction. Check Out What Whales Are Doing With SNPS
- Negative Sentiment: Mixed/softer near‑term guide and China risk — investors reacted to a Q2 revenue guide some saw as light and to commentary about China export restrictions that could mute near‑term growth in that region. Those factors pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
- Negative Sentiment: Acquisition costs, restructuring and debt concerns — reports note GAAP hit from Ansys integration, workforce reductions and the company’s elevated debt load from the transaction; these raise near‑term risk and make investors sensitive to guidance quality. Synopsys Stock (SNPS) Opinions on Earnings Release and AI Outlook
- Negative Sentiment: Analysts trim targets and neutrality rises — several firms cut price targets or lowered ratings after the print (Wells Fargo, Piper Sandler among them), which can add selling pressure even as many analysts remain constructive on AI exposure. Analyst price target and rating changes
Synopsys Trading Down 5.2%
Synopsys stock opened at $426.00 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The stock has a market cap of $81.60 billion, a P/E ratio of 66.15, a PEG ratio of 3.74 and a beta of 1.12. The firm’s fifty day moving average price is $472.21 and its 200-day moving average price is $478.66.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. The business had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same period last year, the firm posted $3.03 earnings per share. Synopsys’s quarterly revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities research analysts forecast that Synopsys will post 10.64 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on SNPS. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Rosenblatt Securities lowered their target price on Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research note on Thursday. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a “buy” rating in a research note on Wednesday. Citigroup started coverage on Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective for the company. Finally, Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Synopsys currently has an average rating of “Hold” and a consensus price target of $535.67.
Get Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
